Craig Boyd has been appointed chief commercial officer, Envigo and Lizanne Muller was named president of EMEA operations. Both of the positions report to Dr. Adrian Hardy, chief executive officer of Envigo.
 

Mr. Boyd has more than 20 years of experience in various global pharmaceutical markets and has worked extensively in the U.S., Asia, Europe and Australia. He previously served as executive vice president of Mayne Pharma’s US specialty brands division. Prior to that, he led the global commercial sales functions at Hospira and Mylan, and spent 10 years as a senior commercial sales and marketing executive at Novartis. In his new role, Craig is responsible for Envigo’s global commercial organization, including, sales, marketing, pricing and customer service activities. 
 
Ms. Muller has 18 years of experience working within a multinational pharmaceutical manufacturing company, and brings extensive commercial experience, specializing in operational finance, continuous improvements, regulatory compliance and change management. Prior to joining Envigo, she spent 16 years at the Dishman Group serving in a variety of roles of increasing responsibility including vice president of Compliance and Governance. She is responsible for Envigo’s Contract Research Services and Research Services Models operations across Europe and Asia.
 
“I am delighted that Craig and Lizanne have joined the team at Envigo and both brought with them great experience and knowledge that has added huge value to the way we work,” said Dr. Hardy. “Their experience and expertise will help us grow Envigo as we continue to focus on delighting our customers with great products and services. It’s a really exciting time at Envigo right now, with emphasis on enhancing our customers’ experience of working with us and cementing our presence as leaders in the markets we serve.”